VySpine’s VyBrate VBR system earned the FDA’s 510(k) clearance, according to a Jan. 13 news release.
The device combines the osseointegration properties of the OXPEKK material and the OsteoVy lattice structure. It is the first vertebral body replacement device on the market made using OsteoVy PEKK.
VySpine’s OsteoVy lattice structure aids in bony integration and wicking, and PEKK implants are designed for an increase in bony apposition over time compared to PEEK.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
